The desired future state of Real World Evidence Generation for guiding new treatments
Galson & Simon (2016) describe a desired future state of RWE generation to include:- addressing the needs of real world stakeholders, incentives to improve RWE research, consensus from payers regarding the role of RWE, guidance from regulatory bodies, more flexible boundaries between premarket and postmarket research, and improved public health from more widely shared real world data.
(Galson and Simon, 2016) ‘Real-World Evidence to Guide the Approval and Use of New Treatments’, Discussion Article